Show simple item record

dc.contributor.authorLi, Yuanyuezh_CN
dc.contributor.authorDai, Congjiezh_CN
dc.contributor.authorLi, Juanzh_CN
dc.contributor.authorWang, Weiweizh_CN
dc.contributor.authorSong, Gangzh_CN
dc.contributor.author李娟zh_CN
dc.contributor.author宋刚zh_CN
dc.date.accessioned2015-07-22T07:36:23Z
dc.date.available2015-07-22T07:36:23Z
dc.date.issued2012zh_CN
dc.identifier.citationONCOTARGETS AND THERAPY, 2012,5:279-286zh_CN
dc.identifier.otherWOS:000309857300001zh_CN
dc.identifier.urihttps://dspace.xmu.edu.cn/handle/2288/93124
dc.descriptionNational Natural Science Foundation of China [31071187, 81272721]; Fundamental Research Funds for the Central Universities [2010121102]; Xiamen Municipal Science and Technology Innovation Fund Project [3502Z20114018]; Program for New Century Excellent Talents in Fujian Province Universityzh_CN
dc.description.abstractBackground: Growing evidence supports BH3-interacting domain death agonist (Bid) playing a dual role in DNA damage response. However, the effects of Bid on hepatocellular carcinoma (HCC) cell proliferation in response to etoposide-induced DNA damage have not been sufficiently investigated. Methods: Using a stable Bid-overexpression HCC cell line, Bid/PLC/PRF/5, overexpression of Bid promoted loss of viability in response to etoposide-induced DNA damage. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]- and BrdU (5'-bromo-2'-deoxyuridine)- labeling assays revealed that etoposide-inhibited HCC cells grew in concentration- and time-dependent manners. The phosphorylations of Akt and mitogen-activated protein kinases (MAPKs) in response to etoposide-induced DNA damage were analyzed by Western blotting. Results: The survival rates of 100 mu M etoposide on the cells with control vector and Bid/PLC/PRF/5 at 48 hours amounted to 71% +/- 0.75% and 59% +/- 0.60% with MTT assay, and similar results of 85% +/- 0.08% and 63% +/- 0.14% with BrdU-labeling assay respectively. Moreover, overexpression of Bid sensitized the cells to apoptosis at a high dose of etoposide (causing irreparable damage). However, it had little effect on the proliferation at a low dose of etoposide (repairable damage). Furthermore, the phosphorylation status of Akt and MAPKs were investigated. Overexpression of Bid suppressed the activation of Akt with respect to etoposideinduced DNA damage. Similar to Akt, the levels of phosphorylated p38 and phosphorylated c-Jun were attenuated by Bid-overexpression. On the contrary, the level of phosphorylated ERK1/2 was sustained at a high level, especially in Bid/PLC/PRF/5 cells. Conclusion: Taken together, these results suggest that overexpression of Bid suppressed the activation of Akt, p38, and c-Jun, and promoted the activation of ERK1/2 induced by etoposide, suggesting that the promotion of ERK1/2 activation may have a negative effect on Bid-mediated HCC DNA damage induced by etoposide.zh_CN
dc.language.isoen_USzh_CN
dc.publisherONCOTARGETS THERzh_CN
dc.source.urihttp://dx.doi.org/10.2147/OTT.S36087zh_CN
dc.subjectGASTRIC-CANCER CELLSzh_CN
dc.subjectSIGNALING PATHWAYSzh_CN
dc.subjectINDUCED APOPTOSISzh_CN
dc.subjectACTIVATIONzh_CN
dc.subjectDEATHzh_CN
dc.subjectSURVIVALzh_CN
dc.subjectMITOCHONDRIAzh_CN
dc.subjectRESISTANCEzh_CN
dc.subjectPROTEINzh_CN
dc.titleBid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cellszh_CN
dc.typeArticlezh_CN


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record